Guilherme Grossi Lopes Cancado
Overview
Explore the profile of Guilherme Grossi Lopes Cancado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cancado G, Deeb M, Gulamhusein A
Hepatology
. 2025 Feb;
PMID: 39960305
Though rare, primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) account for 8-14% of liver transplants (LT) in North America and Europe and the journey of these patients across...
2.
Cancado G, Hirschfield G
Hepatol Commun
. 2025 Jan;
8(12).
PMID: 39774274
Primary sclerosing cholangitis is a chronic liver disease characterized by progressive inflammation and fibrosis of medium-large bile ducts, most commonly in association with inflammatory bowel disease. Most patients have a...
3.
Bittencourt P, Nardelli M, Barros L, Cancado G, Cancado E, Terrabuio D, et al.
Clin Transplant
. 2024 Oct;
38(10):e70002.
PMID: 39436152
Background And Aim: Primary sclerosing cholangitis (PSC) has been shown to recur after liver transplantation (LT). Some studies have identified certain clinical and laboratory variables associated with an increased risk...
4.
Cancado G, Fucuta P, Gomes N, Couto C, Cancado E, Terrabuio D, et al.
Clin Res Hepatol Gastroenterol
. 2024 Aug;
48(8):102453.
PMID: 39174006
Objective: Primary biliary cholangitis is a chronic and progressive autoimmune liver disease, whose prognosis can be improved by normalizing alkaline phosphatase and bilirubin. While ursodeoxycholic acid (UDCA) is first line...
5.
Cancado G, Deeb M, Dodington D, Hirschfield G
J Hepatol
. 2024 Jun;
81(3):577-579.
PMID: 38876804
No abstract available.
6.
7.
Cancado G, Gomes N, Couto C, Cancado E, Terrabuio D, Villela-Nogueira C, et al.
Eur J Gastroenterol Hepatol
. 2024 Mar;
36(5):628-635.
PMID: 38555601
Background: Ursodeoxycholic acid (UDCA) is the standard treatment for primary biliary cholangitis (PBC), but a significant proportion of patients do not respond adequately, leading to increased risk of adverse outcomes....
8.
Guedes L, Cancado G, Santos B, Jacomassi L, Nardelli M, Osorio F, et al.
Ann Hepatol
. 2024 Mar;
29(4):101497.
PMID: 38460715
Introduction And Objectives: Autoimmune hepatitis (AIH) is a rare disease with a complex and not fully understood pathogenesis. Prognostic factors that might influence treatment response, relapse rates, and transplant-free survival...
9.
Mendizabal M, Cancado G, Albillos A
Ann Hepatol
. 2023 Nov;
29(1):101180.
PMID: 37984701
The Baveno VII consensus workshop has provided several novel recommendations regarding the management of patients with clinically significant portal hypertension (CSPH). The expert panel summarized the existing data into simple...
10.
Gelape F, Couto C, Cancado G
Am J Trop Med Hyg
. 2023 Nov;
109(6):1213-1219.
PMID: 37931294
Hepatosplenic schistosomiasis (HSS) is a serious complication of chronic schistosomiasis that can result in portal hypertension and variceal bleeding. β-blockers, a class of medications commonly used to treat hypertension and...